TNF and inflammatory bowel disease: Although great advances in the understanding of IBD have been achieved in recent decades, the diagnosis of IBD is still dependent on the endoscopy examination and histological finding, which are invasive and expensive, and the treatment of IBD is not satisfactory for every patient, despite the development of TNF inhibitors such as infliximab (IFX), which greatly improves the outcome in IBD patients (14–19).